Adriana is a scientist with extensive preclinical research and experimental design experience, spanning the continuum of drug discovery. She graduated with her master’s degree in Genetics from Pennsylvania State University. From 2010 to 2020, Adriana worked at Eli Lilly in several departments, most recently in the Translational Oncology department, where she supported MOA studies of two clinical stage assets.

Adriana joined Stelexis Therapeutics in January 2020 as a Research Scientist on the Cancer Stem Cell Platform team.

In her spare time, Adriana loves crafting.